Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP504960.RA65xFxK9EYQ8HpsmhKtlWpGG5IclBNkdFAG4dhpu2mOs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP504960.RA65xFxK9EYQ8HpsmhKtlWpGG5IclBNkdFAG4dhpu2mOs130_assertion type Assertion NP504960.RA65xFxK9EYQ8HpsmhKtlWpGG5IclBNkdFAG4dhpu2mOs130_head.
- NP504960.RA65xFxK9EYQ8HpsmhKtlWpGG5IclBNkdFAG4dhpu2mOs130_assertion wasGeneratedBy ECO_0000203 NP504960.RA65xFxK9EYQ8HpsmhKtlWpGG5IclBNkdFAG4dhpu2mOs130_provenance.
- NP504960.RA65xFxK9EYQ8HpsmhKtlWpGG5IclBNkdFAG4dhpu2mOs130_assertion wasDerivedFrom befree-20140225 NP504960.RA65xFxK9EYQ8HpsmhKtlWpGG5IclBNkdFAG4dhpu2mOs130_provenance.
- NP504960.RA65xFxK9EYQ8HpsmhKtlWpGG5IclBNkdFAG4dhpu2mOs130_assertion SIO_000772 2121299 NP504960.RA65xFxK9EYQ8HpsmhKtlWpGG5IclBNkdFAG4dhpu2mOs130_provenance.
- NP504960.RA65xFxK9EYQ8HpsmhKtlWpGG5IclBNkdFAG4dhpu2mOs130_assertion evidence source_evidence_literature NP504960.RA65xFxK9EYQ8HpsmhKtlWpGG5IclBNkdFAG4dhpu2mOs130_provenance.
- NP504960.RA65xFxK9EYQ8HpsmhKtlWpGG5IclBNkdFAG4dhpu2mOs130_assertion description "[We have utilized recombinant human interferon alfa-2c to treat 11 patients with Philadelphia chromosome positive chronic myelogenous leukemia in chronic phase, who were resistant to previous interferon gamma therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP504960.RA65xFxK9EYQ8HpsmhKtlWpGG5IclBNkdFAG4dhpu2mOs130_provenance.